Opinion

Video

Evolving Commercialization and Distribution Models for PDTs

The panel discusses the challenges of delivering prescription digital therapeutics (PDTs) to patients, challenges caused by PDTs being considered behavioral health benefits, pharmacy benefits, medical benefits, and durable medical equipment benefits.

Related Videos
Dan Nardi
Andrew Kuykendall, MD, Moffitt Cancer Center
4 experts are featured in this series.
1 expert is featured in this series.
Anna Mueller, MD, Mount Sinai
Marc Humbert, MD, PhD
John Ostrominski, MD
Related Content
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo